These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 30100292)
1. Integration of a neurodynamic approach into the treatment of dysarthria for patients with idiopathic Parkinson's disease: A pilot study. Ateras B; von Piekartz H J Bodyw Mov Ther; 2018 Jul; 22(3):648-656. PubMed ID: 30100292 [TBL] [Abstract][Full Text] [Related]
2. Speech and language therapy treatment on hypokinetic dysarthria in Parkinson disease: Systematic review and meta-analysis. Muñoz-Vigueras N; Prados-Román E; Valenza MC; Granados-Santiago M; Cabrera-Martos I; Rodríguez-Torres J; Torres-Sánchez I Clin Rehabil; 2021 May; 35(5):639-655. PubMed ID: 33233932 [TBL] [Abstract][Full Text] [Related]
3. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease. Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045 [TBL] [Abstract][Full Text] [Related]
4. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial. Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410 [TBL] [Abstract][Full Text] [Related]
5. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease. Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195 [TBL] [Abstract][Full Text] [Related]
6. Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson's disease: A pilot study. Quinn R; Park S; Theodoros D; Hill AJ Int J Speech Lang Pathol; 2019 Aug; 21(4):385-394. PubMed ID: 29879854 [No Abstract] [Full Text] [Related]
7. [Speech therapy for the dysarthria of Parkinson's disease]. Ozsancak C; Auzou P Rev Neurol (Paris); 2005 Sep; 161(8-9):857-61. PubMed ID: 16244572 [TBL] [Abstract][Full Text] [Related]
8. Speech and language therapy for dysarthria in Parkinson's disease. Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044 [TBL] [Abstract][Full Text] [Related]
9. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease. Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176 [TBL] [Abstract][Full Text] [Related]
10. Internet delivery of intensive speech and language therapy for children with cerebral palsy: a pilot randomised controlled trial. Pennington L; Stamp E; Smith J; Kelly H; Parker N; Stockwell K; Aluko P; Othman M; Brittain K; Vale L BMJ Open; 2019 Jan; 9(1):e024233. PubMed ID: 30705241 [TBL] [Abstract][Full Text] [Related]
11. Game-Based Augmented Visual Feedback for Enlarging Speech Movements in Parkinson's Disease. Yunusova Y; Kearney E; Kulkarni M; Haworth B; Baljko M; Faloutsos P J Speech Lang Hear Res; 2017 Jun; 60(6S):1818-1825. PubMed ID: 28655041 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of Lee Silverman Voice Treatment therapy issued interactively through an iPad device: A non-inferiority study. Griffin M; Bentley J; Shanks J; Wood C J Telemed Telecare; 2018 Apr; 24(3):209-215. PubMed ID: 28147896 [TBL] [Abstract][Full Text] [Related]
14. Incorporating the Principles of Self-Management into Treatment of Dysarthria Associated with Parkinson's Disease. Yorkston K; Baylor C; Britton D Semin Speech Lang; 2017 Jul; 38(3):210-219. PubMed ID: 28618444 [TBL] [Abstract][Full Text] [Related]
15. [The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)]. Kamińska I; Zebryk-Stopa A; Pruszewicz A; Dziubalska-Kołaczyk K; Połczyńska-Fiszer M; Pietrala D; Przedpelska-Ober E Otolaryngol Pol; 2007; 61(5):713-8. PubMed ID: 18552005 [TBL] [Abstract][Full Text] [Related]
16. Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS. Vogel AP; Stoll LH; Oettinger A; Rommel N; Kraus EM; Timmann D; Scott D; Atay C; Storey E; Schöls L; Synofzik M J Neurol; 2019 May; 266(5):1260-1266. PubMed ID: 30840144 [TBL] [Abstract][Full Text] [Related]
17. Markerless Analysis of Articulatory Movements in Patients With Parkinson's Disease. Bandini A; Orlandi S; Giovannelli F; Felici A; Cincotta M; Clemente D; Vanni P; Zaccara G; Manfredi C J Voice; 2016 Nov; 30(6):766.e1-766.e11. PubMed ID: 26620259 [TBL] [Abstract][Full Text] [Related]
18. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease. Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934 [TBL] [Abstract][Full Text] [Related]
19. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy. Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088 [TBL] [Abstract][Full Text] [Related]
20. The living with dysarthria group: implementation and feasibility of a group intervention for people with dysarthria following stroke and family members. Mackenzie C; Paton G; Kelly S; Brady M; Muir M Int J Lang Commun Disord; 2012; 47(6):709-24. PubMed ID: 23121529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]